AASLD Practice Statement on the evaluation and management of metabolic dysfunction-associated steatotic liver disease in children
- PMID: 40300071
- DOI: 10.1097/HEP.0000000000001368
AASLD Practice Statement on the evaluation and management of metabolic dysfunction-associated steatotic liver disease in children
Keywords: NAFLD; children; cirrhosis; fatty liver disease; fibrosis; metabolic dysfunction; obesity; steatohepatitis.
References
-
- Ayonrinde OT. Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD—Reconciling the present with the past. JHEP Rep. 2021;3:100261.
-
- Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797–1835.
-
- Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966–1986.
-
- European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), European Association for the Study of the Liver (EASL), North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) et al. Paediatric steatotic liver disease has unique characteristics: A multisociety statement endorsing the new nomenclature. J Pediatr Gastroenterol Nutr. 2024;78:1190–1196.
-
- Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388–1393.
LinkOut - more resources
Full Text Sources
